• Posted: March 2, 2017 Myeloma's "Achilles Heels" at IMW 2017

    Get updates from the 2017 International Myeloma Workshop in New Delhi, India

    READ MORE
  • Posted: February 24, 2017 What to Expect: Targeted Therapies

    Targeted therapy is a type of cancer treatment that specifically targets the molecules that benefit cancer cells in order to block those cells from growing,...

    READ MORE
  • Posted: February 22, 2017 Plasma cell disorders and myeloma terminology and classifications

    Multiple myeloma, solitary plasmacytoma, smoldering myeloma, MGUS . . . what’s the difference? All of these disorders are related, but they have different...

    READ MORE
  • Posted: January 5, 2017 Facebook LIVE Follow-Up Notes from Traver Hutchins

    Following part 4 of MMRF Social Ambassador Traver Hutchin's SCT Facebook Live series, Traver has shared follow-up notes to help viewers continue their own...

    READ MORE
  • Posted: December 6, 2016 MMRF-Led Immunotherapy Approaches Make a Splash at ASH

    The third day of the 58th Annual ASH Meeting offered numerous exciting presentations about several up-and-coming approaches to treating myeloma with...

    READ MORE
  • Posted: December 5, 2016 4 Promising Myeloma Treatments Bring Hope to Patients

    Day 2 of the 58th Annual ASH Meeting included exciting results from several studies of new therapies being examined in clinical trials; the MMRC, the clinical...

    READ MORE
  • Posted: December 4, 2016 Record-Breaking CoMMpass Results Presented at World's Premier Hematology Event

    The world’s largest society of hematology professionals—American Society of Hematology (ASH)—kicked off its annual meeting today in San Diego. More than...

    READ MORE
  • Posted: December 2, 2016 MMRF Recognizes Two Outstanding Organizations at 58th ASH Annual Meeting

    The Multiple Myeloma Research Foundation (MMRF) announced at the 57th ASH Annual Meeting the recipients of its three awards for outstanding acceleration,...

    READ MORE
  • Posted: December 2, 2016 Resources from the 2016 MMRF ASH Satellite Symposium

    The multiple myeloma (MM) therapeutic landscape has significantly expanded, with 10 new drug approvals in the last 12 years. To help hematologist-oncologists...

    READ MORE
  • Posted: December 1, 2016 Groundbreaking MMRF CoMMpass Study℠ Affirmed as Premier Genomics Data Set in...

    The Multiple Myeloma Research Foundation (MMRF) today announced that 19 research presentations from the MMRF CoMMpass StudySM—the largest and most...

    READ MORE

Page 4/15